000 | 01621 a2200433 4500 | ||
---|---|---|---|
005 | 20250515223434.0 | ||
264 | 0 | _c20100827 | |
008 | 201008s 0 0 eng d | ||
022 | _a1873-2518 | ||
024 | 7 |
_a10.1016/j.vaccine.2010.04.081 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aEggert, Dawn | |
245 | 0 | 0 |
_aCharacterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry. _h[electronic resource] |
260 |
_bVaccine _cJun 2010 |
||
300 |
_a4609-15 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCentral America |
650 | 0 | 4 |
_aChickens _ximmunology |
650 | 0 | 4 |
_aFowlpox virus _ximmunology |
650 | 0 | 4 | _aHemagglutination Inhibition Tests |
650 | 0 | 4 |
_aHemagglutinin Glycoproteins, Influenza Virus _ximmunology |
650 | 0 | 4 |
_aInfluenza A Virus, H5N2 Subtype _ximmunology |
650 | 0 | 4 |
_aInfluenza Vaccines _ximmunology |
650 | 0 | 4 |
_aInfluenza in Birds _ximmunology |
650 | 0 | 4 |
_aPoultry _xvirology |
650 | 0 | 4 | _aSpecific Pathogen-Free Organisms |
650 | 0 | 4 |
_aVaccines, Inactivated _ximmunology |
650 | 0 | 4 |
_aVaccines, Synthetic _ximmunology |
650 | 0 | 4 | _aVirus Shedding |
700 | 1 | _aThomas, Colleen | |
700 | 1 | _aSpackman, Erica | |
700 | 1 | _aPritchard, Nikki | |
700 | 1 | _aRojo, Francisco | |
700 | 1 | _aBublot, Michel | |
700 | 1 | _aSwayne, David E | |
773 | 0 |
_tVaccine _gvol. 28 _gno. 29 _gp. 4609-15 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2010.04.081 _zAvailable from publisher's website |
999 |
_c19825120 _d19825120 |